Gemphire Therapeutics Announces Departure of Its Chief Executive Officer Mina Sooch
May 30, 2017 20:05 pm UTC| Business
LIVONIA, Mich., May 30, 2017 -- Gemphire Therapeutics Inc. (Nasdaq:GEMP) announced today that Mina Sooch, President, CEO, and Director of the Company has resigned for personal reasons effective May 23, 2017. Dr. Steven...
Invuity to Present at William Blair Growth Stock Conference
May 30, 2017 20:04 pm UTC| Business
SAN FRANCISCO, May 30, 2017 -- Invuity, Inc. (NASDAQ:IVTY), an advanced surgical illumination company focused on minimal access surgery, today announced that company management is scheduled to present at the William...
Allscripts achieves full 2015 edition certification across all EHRs with Drummond Group LLC
May 30, 2017 20:04 pm UTC| Business
CHICAGO, May 30, 2017 -- Through its partnership with Drummond Group LLC, Allscripts (NASDAQ:MDRX) newest versions of Sunrise and TouchWorks EHR are now certified for the 2015 Edition requirements that support...
Invuity to Present at William Blair Growth Stock Conference
May 30, 2017 20:04 pm UTC| Business
SAN FRANCISCO, May 30, 2017 -- Invuity, Inc. (NASDAQ:IVTY), an advanced surgical illumination company focused on minimal access surgery, today announced that company management is scheduled to present at the William...
Allscripts achieves full 2015 edition certification across all EHRs with Drummond Group LLC
May 30, 2017 20:04 pm UTC| Business
CHICAGO, May 30, 2017 -- Through its partnership with Drummond Group LLC, Allscripts (NASDAQ:MDRX) newest versions of Sunrise and TouchWorks EHR are now certified for the 2015 Edition requirements that support...
Allscripts achieves full 2015 edition certification across all EHRs with Drummond Group LLC
May 30, 2017 20:04 pm UTC| Business
CHICAGO, May 30, 2017 -- Through its partnership with Drummond Group LLC, Allscripts (NASDAQ:MDRX) newest versions of Sunrise and TouchWorks EHR are now certified for the 2015 Edition requirements that support...
May 30, 2017 20:03 pm UTC| Business
BOSTON, May 30, 2017 -- Albireo Pharma, Inc. (NASDAQ:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today the completion of its previously announced...
Viksit Bharat 2026: Fiscal Muscle, Factory Revival, and the War on Speculation